Market Tracker

12/05 3:36pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.28
BATS BZX Real-Time Price
As of 3:33pm ET
 +0.125 / +0.88%
Today’s Change
7.86
Today|||52-Week Range
17.05
-3.81%
Year-to-Date

Today’s Trading

Previous close14.15
Today’s open14.45
Day’s range14.10 - 14.75
Volume25,986
Average volume (3 months)609,419
Market cap$1.0B
Dividend yield--
Data as of 3:33pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+14.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.64

Competitors

 Today’s
change
Today’s
% change
AMAGAMAG Pharmaceuticals...+0.82+2.48%
CHRSCoherus BioSciences ...+0.35+1.25%
CRSPCRISPR Therapeutics ...+1.51+7.93%
RTRXRetrophin Inc+0.43+2.15%
Data as of 3:36pm ET, 12/05/2016

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts